Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

Download as PDF

MINNEAPOLIS, MN (May 30, 2018) – Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a
medical technology company focused on the development and commercialization of innovative and
minimally invasive solutions for patients with obstructive sleep apnea, announced today that its
management team will be presenting at the Goldman Sachs 39th Annual Global Healthcare Conference on
June 12, 2018 at the Terranea Resort in Rancho Palos Verdes, California.

Inspire is scheduled to present at 10:00 a.m. Pacific Time. The presentation will be accessible via a live
webcast, accessible at: https://cc.talkpoint.com/gold006/061218a_as/?entity=59_O7M1CJB
A webcast replay of the presentation will be available on the Investor section of Inspire’s website at
www.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of
innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire Medical
Systems’ proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that
provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For more
information, please visit www.inspiresleep.com.

Inspire Investor and Media Contact
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989